Identification of CSRP1 as novel biomarker for hormone-sensitive prostate cancer by the combination of clinical and functional research
Abstract Prostate cancer (PCa) ranks as the second most common malignancy and the fifth leading cause of cancer-related deaths among men. A critical challenge lies in accurately identifying those patients at high risk for transitioning rapidly from hormone-sensitive PCa (HSPC) to lethal castration-r...
Furkejuvvon:
| Váldodahkkit: | , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
BMC
2025-02-01
|
| Ráidu: | Cancer Cell International |
| Fáttát: | |
| Liŋkkat: | https://doi.org/10.1186/s12935-025-03708-y |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|
